Review: Stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetes
- Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3). // Journal of Neurology, Neurosurgery & Psychiatry;Apr2008, Vol. 79 Issue 4, p397
Background and Purpose: Models are used to adjust for case mix and to stratify treatment allocation in clinical trials and can, if accurate enough, be used to aid decision-making in individual patients. We aimed to validate, in patients assessed within 6 hours of onset, a previously described...
- Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Fink, Matthew E. // Neurology Alert;Jun2010, Vol. 28 Issue 10, p80
The article discusses research on the safety of tissue plasminogen activator (tPA) in patients who are suffering from neuroimaging-negative cerebral ischemia and stroke, referencing a study by O. Y. Chernyshev and colleagues, published in the 2010 issue of "Neurology."
- Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Sharkey, John; Butcher, Steven P. // Nature;9/22/1994, Vol. 371 Issue 6495, p336
Features the neuroprotective properties of the immunosuppressive drug FK506 in an in vivo model of focal cerebral ischemia. Minimum effective dose; Clinical potential for treatment of stroke; Confirmation of role of immunophilins in the neuroprotective mechanism.
- Prevention and treatment of brain ischaemia. Hinds, C.J. // British Medical Journal (Clinical Research Edition);9/21/1985, Vol. 291 Issue 6498, p758
Examines the prevention and treatment of brain ischemia. Definition of cerebral ischemia; Modification of ischemia by the residual flow; Assessment on the decrease of cerebral blood flow.
- Are Anticoagulants Better than Antiplatelet Agents for Treatment of Acute Ischemic Stroke? Griffin, Glenn // American Family Physician;10/1/2003, Vol. 68 Issue 7, p1307
Presents a study that compared the effectiveness of unfractionated heparin, low-molecular-weight heparin and aspirin in treating acute ischemic stroke among patients in the U.S. Background on the therapeutic use of antiplatelet agents and anticoagulants for the disease; Method that should be...
- Neonatal Nonketotik Hiperglisinemi: Ä°ki Olgu Sunumu. €elik, Yalın; Glaşı, Selvi; Atıcı, Aytuğ; Kmr, Mustafa; Turhan, Ali Haydar; Bolat, Ergl // Journal of Current Pediatrics / Guncel Pediatri;Dec2011, Vol. 9 Issue 3, p137
Introduction: Nonketotic hyperglycinemia is an autosomal recessive disorder of glycine metabolism caused by a defect in the glycine cleavage system. Case 1: A 3-day-old female baby was admitted to emergency room of a public hospital due to cyanosis and was hospitalized after resuscitation. She...
- The ups and downs of dipsticks. R.M.D. // Cortlandt Forum;6/25/96, Vol. 9 Issue 6, p89
Discusses the merits of dipstick screening done in the United States for hyperglycemia. Urine glucose dipsticks as the cheapest and least invasive way in screening hyperglycemia; Procedure for the accurate and true result of the dipstick screening for athletes.
- SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly. Altieri, M. // Neurological Sciences;Apr2002, Vol. 23 Issue 1, p23
We investigated the clinical outcome and current therapeutic management of ischemic stroke in elderly patients in different neurological wards throughout Italy. Twelve centers in 10 Italian regions were involved. The clinical and instrumental data were prospectively collected for 335 patients 65...
- Recent Advances in Adenovirus-mediated Gene Therapy for Cerebral Ischemia. Masumura, Makoto; Hata, Ryuji // Current Gene Therapy;Feb2003, Vol. 3 Issue 1, p43
Cerebral ischemia induces many degenerative cellular reactions, including the release of excitatory amino acids, the formation of oxygen free radicals, Ca2+ overload, the activation of several cellular enzyme systems such as Ca2+dependent proteases, and the initiation of genomic responses that...